PRGX Global (PRGX) 10-Q 11 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Apr. 30, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	PRGX GLOBAL, INC.
Entity Central Index Key	0001007330
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		23,592,375
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Current Reporting Status	Yes

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue, net	$ 36,839	$ 38,804
Operating expenses:
Cost of revenue	22,534	25,235
Selling, general and administrative expenses	13,464	13,917
Depreciation of property, equipment and software assets	2,141	2,203
Amortization of intangible assets	829	862
Total operating expenses	38,968	42,217
Operating loss from continuing operations	(2,129)	(3,413)
Foreign currency transaction losses on short-term intercompany balances	1,456	206
Interest expense, net	342	473
Other income	0	(19)
Loss from continuing operations before income tax	(3,927)	(4,073)
Income tax (benefit) expense	(44)	168
Net loss from continuing operations	(3,883)	(4,241)
Discontinued operations:
Loss from discontinued operations	0	(155)
Net loss from discontinued operations	0	(155)
Net loss	$ (3,883)	$ (4,396)
Basic loss per common share (Note 2):
Basic (loss) income from continuing operations (in usd per share)	$ (0.17)	$ (0.19)
Basic income (loss) from discontinued operations (in usd per share)	0	(0.01)
Total basic net loss per common share	(0.17)	(0.20)
Diluted loss per common share (Note 2):
Diluted (loss) income from continuing operations (in usd per share)	(0.17)	(0.19)
Diluted income (loss) from discontinued operations (in usd per share)	0	(0.01)
Total diluted (loss) income per common share (in usd per share)	$ (0.17)	$ (0.20)
Weighted-average common shares outstanding (Note 2):
Basic	22,488	22,610
Diluted	22,488	22,610

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net loss	$ (3,883)	$ (4,396)
Foreign currency translation adjustments, net of tax	(1,948)	513
Comprehensive loss	$ (5,831)	$ (3,883)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 25,233	$ 14,982
Restricted cash	81	46
Contract receivables, less allowances of $1,291 in 2020 and $1,781 in 2019
Billed	31,747	38,201
Unbilled	3,252	4,911
Receivables Net	34,999	43,112
Employee advances and miscellaneous receivables, net	631	704
Total receivables	35,630	43,816
Prepaid expenses and other current assets	3,004	5,582
Total current assets	63,948	64,426
Property, equipment and software	63,730	63,557
Less accumulated depreciation and amortization	(45,754)	(45,811)
Property, equipment and software, net	17,976	17,746
Operating lease right-of-use assets (Note 9)	9,817	10,969
Goodwill	14,965	15,070
Intangible assets, less accumulated amortization of $47,391 in 2020 and $47,097 in 2019	10,545	11,506
Unbilled receivables	757	1,282
Deferred income taxes	3,623	3,921
Other assets	535	546
Total assets	122,166	125,466
Current liabilities:
Accounts payable and accrued expenses	1,049	4,326
Accrued payroll and related expenses	11,883	12,951
Current portion of operating lease liabilities (Note 9)	3,757	3,717
Refund liabilities	4,059	4,513
Deferred revenue	1,789	2,217
Current portion of debt (Note 5)	4	17
Total current liabilities	22,541	27,741
Long-term debt (Note 5)	44,627	36,603
Long-term operating lease liabilities (Note 9)	6,386	7,435
Refund liabilities	6	9
Deferred income taxes (Note 8)	628	628
Total liabilities	74,188	72,416
Commitments and contingencies (Note 7)
Shareholders’ equity (Note 2):
Common stock, no par value; $.01 stated value per share. Authorized 50,000,000 shares; 23,595,079 shares issued and outstanding at March 31, 2020 and 23,369,433 shares issued and outstanding at December 31, 2019	236	234
Additional paid-in capital	583,161	582,404
Accumulated deficit	(533,059)	(529,176)
Accumulated other comprehensive loss	(2,360)	(412)
Total shareholders’ equity	47,978	53,050
Total liabilities and shareholders' equity	$ 122,166	$ 125,466

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Allowances for contract receivables	$ 1,291	$ 1,781
Accumulated amortization on intangible assets	$ 47,391	$ 47,097
Common stock, par value (in usd per share)
Common stock, stated value per share (in usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	23,595,079	23,369,433
Common stock, shares outstanding (in shares)	23,595,079	23,369,433

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning balance (in shares) at Dec. 31, 2018		23,186,258
Beginning balance at Dec. 31, 2018	$ 66,329	$ 232	$ 582,574	$ (515,456)	$ (1,021)
Increase (Decrease) in Stockholders' Equity
Net (loss) income	(4,396)			(4,396)
Foreign currency translation adjustments	513				513
Issuances of common stock:
Restricted share awards (in shares)		333,552
Restricted share awards	0	$ 3	(3)
Restricted shares remitted by employees for taxes (in shares)		61,581
Restricted shares remitted by employees for taxes	(504)	$ (1)	(503)
Stock option exercises (in shares)		10,061
Stock option exercises	51		51
Performance-based restricted stock unit settlement (in shares)		203,524
Performance-based restricted stock unit settlement		$ 2	(2)
Restricted stock unit settlement (in shares)		9,999
Restricted stock unit settlement	0
Repurchase of common stock (in shares)		(243,755)
Repurchase of common stock	(2,228)	$ (2)	(2,226)
Stock-based compensation expense	1,465		1,465
Ending balance (in shares) at Mar. 31, 2019		23,438,058
Ending balance at Mar. 31, 2019	$ 61,230	$ 234	581,356	(519,852)	(508)
Beginning balance (in shares) at Dec. 31, 2019	23,369,433	23,369,433
Beginning balance at Dec. 31, 2019	$ 53,050	$ 234	582,404	(529,176)	(412)
Increase (Decrease) in Stockholders' Equity
Net (loss) income	(3,883)			(3,883)
Foreign currency translation adjustments	(1,948)				(1,948)
Issuances of common stock:
Restricted share awards (in shares)		398,500
Restricted share awards	0	$ 4	(4)
Restricted shares remitted by employees for taxes (in shares)		(84,043)
Restricted shares remitted by employees for taxes	(283)	$ (1)	(282)
Restricted stock unit settlement (in shares)		44,002
Restricted stock unit settlement	0
Forfeited restricted share awards (in shares)		(28,951)
Forfeited restricted share awards	$ 0
Repurchase of common stock (in shares)	(103,862)
Repurchase of common stock	$ (284)	$ (1)	(283)
Stock-based compensation expense	$ 1,326		1,326
Ending balance (in shares) at Mar. 31, 2020	23,595,079	23,595,079
Ending balance at Mar. 31, 2020	$ 47,978	$ 236	$ 583,161	$ (533,059)	$ (2,360)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (3,883)	$ (4,396)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	2,970	3,065
Operating lease right-of-use asset expense	1,152	1,135
Amortization of deferred loan costs	24	56
Noncash interest expense	345	0
Stock-based compensation expense	1,320	1,384
Foreign currency transaction losses on short-term intercompany balances	1,456	206
Deferred income taxes	338	0
Changes in operating assets and liabilities
Billed receivables	5,131	4,413
Unbilled receivables	(2,184)	(939)
Prepaid expenses and other current assets	2,583	516
Operating lease liabilities	(1,009)	(1,093)
Other assets	(64)	(65)
Accounts payable and accrued expenses	(5,800)	(3,048)
Accrued payroll and related expenses	(760)	(4,938)
Refund liabilities	(355)	(537)
Deferred revenue	(400)	(45)
Net cash provided by (used in) operating activities	5,232	(2,408)
Cash flows from investing activities:
Purchases of property, equipment and software, net of disposal proceeds	(2,517)	(4,441)
Net cash used in investing activities	(2,517)	(4,441)
Cash flows from financing activities:
Repayments of credit facility	(15,000)	0
Proceeds from credit facility	23,000	8,400
Payment of deferred loan costs	0	(347)
Payment of earnout liability related to business acquisitions	0	(479)
Restricted stock repurchased from employees for withholding taxes	(283)	(504)
Repurchases of common stock	(284)	(2,228)
Proceeds from option exercises	0	51
Net cash provided by financing activities	7,433	4,893
Effect of exchange rates on cash and cash equivalents	138	170
Net increase (decrease) in cash, cash equivalents and restricted cash	10,286	(1,786)
Cash, cash equivalents and restricted cash at beginning of period	15,028	13,973
Cash, cash equivalents and restricted cash at end of period	25,314	12,187
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	371	325
Cash paid during the period for income taxes, net of refunds received	$ 164	$ 779

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Condensed Consolidated Financial Statements (Unaudited) of PRGX Global, Inc. and its wholly-owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions for the Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three -month period ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020 . Except as otherwise indicated or unless the context otherwise requires, “PRGX,” “we,” “us,” “our” and the “Company” refer to PRGX Global, Inc. and its subsidiaries. For further information, refer to the Consolidated Financial Statements and the related Notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . Significant Accounting Policies A summary of the Company's significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. The Company did not experience any significant changes during the quarter ended March 31, 2020 in any of the Critical Accounting Policies from those contained in the Company's Form 10-K for the year ended December 31, 2019. COVID-19 In December 2019, a novel strain of coronavirus was first identified, and in March 2020, the World Health Organization categorized COVID-19, the disease resulting from this coronavirus strain, as a pandemic. To help control the spread of the virus and protect the health and safety of our employees and customers, many of the Company's teams worldwide have been working remotely since the middle of March. The Company evaluates the recoverability of goodwill annually in the fourth quarter of each year or sooner if events or changes in circumstances indicate that the carrying amount may exceed its fair value. The impairment test performed in the fourth quarter of 2019 indicated significant excess fair value over carrying value for the Recovery Audit Services reporting units. The Company evaluated whether there were indicators of impairment as of March 31, 2020 as a result of COVID-19 conditions including deterioration in the macro-economic environment and the volatility in our share price. While our share price was depressed, and there were negative macro-economic factors, the positive evidence outweighed the negative evidence of the fair value of our reporting units more likely than not exceeding the carrying amount of those units as of March 31, 2020. Further, since the negative financial impacts from the COVID-19 pandemic have not been significant to date, COVID-19 considerations do not significantly affect the assumptions underpinning our long-term revenue and cash flow growth rates, operating models and business strategies. Therefore, the Company did not consider the COVID-19 pandemic to require an interim quantitative goodwill impairment analysis. As a result, no impairment charges for goodwill and indefinite-lived intangible assets were recorded during the quarter. The Company also evaluated its remaining assets, particularly accounts receivable. The allowance for doubtful accounts is calculated based on historical experience and various other information available. The Company also assessed incremental risks due to the COVID-19 pandemic on our customers' financial viability. The Company did not experience a significant deterioration of its accounts receivable portfolio. The Company will continue to monitor the collectability of its accounts receivable balances. The Company expects to receive an immaterial amount of COVID-19-related rent concessions for certain office space leases in the second quarter of 2020. Consistent with updated guidance from the Financial Accounting Standards Board (“FASB”) in April 2020, the Company elected to treat COVID-19-related rent concessions as variable rent. While the Company is having ongoing conversations with landlords, it does not expect significant concessions for the remainder of the year. On March 27, 2020, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which among other things, provides employer payroll tax credits for wages paid to employees who are unable to work during the COVID-19 pandemic and options to defer payroll tax payments. Based on preliminary evaluation of the CARES Act, the Company qualifies for certain employer payroll tax credits as well as the deferral of payroll and other tax payments in the future, which will be treated as government subsidies to offset relating operating expenses. The Company intends to defer qualified payroll and other tax payments as permitted by the CARES Act. The full extent of the future impact of COVID-19 and any non-income tax CARES Act provision on the Company’s operations is uncertain. Such events including a prolonged or recurring outbreak are generally outside of our control and could have a material adverse impact on our business, operating results and financial conditions in future reporting periods. Impact of Recently Issued Accounting Standards A summary of the new accounting standards issued by the FASB and included in the Accounting Standards Codification ("ASC") that apply to PRGX is included below: Adopted by the Company in Fiscal Year 2020 FASB ASU 2018-13 - In August 2018, the FASB issued Accounting Standards Update ("ASU") 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement , which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public companies are required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. Certain provisions of the ASU must be applied retrospectively, while others must be applied prospectively. The Company adopted this ASU on January 1, 2020. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements. FASB ASU 2018-15 - In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract , which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted this ASU prospectively on January 1, 2020. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements. Accounting Standards Not Yet Adopted FASB ASU 2016-13 - In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which requires entities to record expected credit losses for certain financial instruments, including trade receivables, as an allowance that reflects the entity's current estimate of credit losses expected to be incurred. ASU 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods, and early adoption is permitted. The Company is currently evaluating the effect that the adoption of this standard will have on the Company's condensed consolidated financial statements. FASB ASU 2019-12 - In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which simplifies accounting for income taxes, changes the accounting for certain income tax transactions and makes certain improvements to the codification. These amendments will be effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the new standard to determine the impact it will have on the Company’s condensed consolidated financial statements. FASB ASU 2020-04 - In March 2020, the FASB issued ASU No. 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (LIBOR) and other interbank offered rates. Companies may adopt this guidance at any time but no later than December 31, 2022. The Company is currently evaluating the new standard to determine the impact it will have on the Company’s condensed consolidated financial statements.

Net Loss Per Common Share

Net Loss Per Common Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Net Loss Per Common Share	Net Loss Per Common Share The following table sets forth the computations of basic and diluted net loss per common share for the three months ended March 31, 2020 and 2019 (in thousands, except per share data): Three Months 2020 2019 Numerator: Net loss from continuing operations $ (3,883 ) $ (4,241 ) Net loss from discontinued operations $ — $ (155 ) Denominator: Weighted-average common shares outstanding 22,488 22,610 Basic net loss per common share from continuing operations $ (0.17 ) $ (0.19 ) Basic net loss per common share from discontinued operations — (0.01 ) Total basic net loss per common share $ (0.17 ) $ (0.20 ) Diluted loss per common share from continuing operations $ (0.17 ) $ (0.19 ) Diluted loss per common share from discontinued operations — (0.01 ) Total diluted loss per common share $ (0.17 ) $ (0.20 ) Anti-dilutive securities excluded from diluted net loss per share calculation 5,263 4,139

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company has two stock-based compensation plans under which outstanding equity awards have been granted, the 2008 Equity Incentive Plan ("2008 EIP") and the 2017 Equity Incentive Compensation Plan ("2017 EICP") (collectively, the "Plans"). No additional awards may be granted under the 2008 EIP. Awards granted outside of the Plans are referred to as inducement awards. During the three months ended March 31, 2020, equity awards were granted to certain key employees. The awards included restricted stock awards, restricted stock units, and performance-based restricted stock units ("PBUs"). Summary of Grant Activity The following is a summary of grant activity for the three months ended March 31, 2020 (in thousands, except number of awards): Three Months Ended March 31, 2020 # of Awards Granted Grant Date Fair Value Restricted stock 398,500 $ 1,710 Restricted stock units 19,000 82 PBUs 659,301 2,828 1,076,801 $ 4,620 The awards granted in the three months ended March 31, 2020 had the following terms: • The restricted stock and restricted stock units vest over three years in approximately equal annual installments. • The vesting of the PBUs is subject to the satisfaction of certain specified financial performance conditions for the two -year performance period ending on December 31, 2021. PBUs that vest will be settled in shares of the Company's common stock. Stock-based compensation expense for these PBUs is being recognized at the target level of financial performance, as if 100% of the awards will vest. The Company reevaluates this likelihood on a quarterly basis. Additional Information As of March 31, 2020 , there were approximately 0.9 million shares available for future grant under the 2017 EICP. Stock-based compensation expense for the three months ended March 31, 2020 and 2019 was $1.3 million and $1.4 million , respectively, and is included in Selling, general and administrative expenses in the Company's Condensed Consolidated Statement of Operations. As of March 31, 2020 , there was $9.0 million of unrecognized stock-based compensation expense related to the Company's outstanding equity awards which will be recognized over approximately 2.0 years .

Operating Segments and Related

Operating Segments and Related Information	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Operating Segments and Related Information	Operating Segments and Related Information The Company conducts its operations through the following three reportable segments: Recovery Audit Services – Americas represents recovery audit services provided in the United States of America (“U.S.”), Canada and Latin America. Recovery Audit Services – Europe/Asia-Pacific represents recovery audit services provided in Europe, Asia and the Pacific region. Adjacent Services represents data transformation, spend analytics and associated advisory services. The unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the three reportable segments is included in Corporate Support . Discontinued Operations There is no activity in the Company's discontinued operations segment for the three months ended March 31, 2020. The following table presents the discontinued operations of the Healthcare Claims Recovery Audit ("HCRA") services business in the Consolidated Statement of Operations, for the three months ended March 31, 2019 (in thousands): Three Months Ended March 31, 2019 Revenue, net $ — Cost of sales 149 Selling, general and administrative expense 6 Depreciation and amortization — Loss from discontinued operations before income taxes $ (155 ) Income tax expense — Loss from discontinued operations $ (155 ) The following table presents the discontinued operations of the HCRA services business in the Consolidated Statements of Cash Flows, for the three months ended March 31, 2019 (in thousands): Three Months Ended March 31, 2019 Net cash used in operating activities $ (155 ) Net cash (used in) provided by investing activities — Net cash (used in) provided by financing activities — Decrease in cash and cash equivalents $ (155 ) The Company evaluates the performance of its reportable segments based upon revenue and measures of profit or loss referred to as EBITDA and Adjusted EBITDA. The Company defines Adjusted EBITDA as earnings from continuing operations before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains, acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, certain severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant. The Company does not have any inter-segment revenue. Segment information for the three months ended March 31, 2020 and 2019 (in thousands) is as follows: Recovery Audit Services – Americas Recovery Audit Services – Europe/Asia- Pacific Adjacent Services Corporate Support Total Three Months Ended March 31, 2020 Revenue, net $ 26,223 $ 9,785 $ 831 $ — $ 36,839 Net loss from continuing operations (3,883 ) Income tax benefit (44 ) Interest expense, net 342 EBIT $ 4,478 $ 1,439 $ 138 $ (9,640 ) $ (3,585 ) Depreciation of property, equipment and software 1,938 169 34 — 2,141 Amortization of intangible assets 408 42 379 — 829 EBITDA $ 6,824 $ 1,650 $ 551 $ (9,640 ) $ (615 ) Foreign currency transaction losses (gains) on short-term intercompany balances 896 874 4 (318 ) 1,456 Transformation, severance, and other expenses 688 208 80 331 1,307 Stock-based compensation — — — 1,320 1,320 Adjusted EBITDA from continuing operations $ 8,408 $ 2,732 $ 635 $ (8,307 ) $ 3,468 Recovery Audit Services – Americas Recovery Audit Services – Europe/Asia- Pacific Adjacent Services Corporate Support Total Three Months Ended March 31, 2019 Revenue, net $ 27,373 $ 9,759 $ 1,672 $ — $ 38,804 Net loss from continuing operations (4,241 ) Income tax expense 168 Interest expense, net 473 EBIT $ 6,004 $ 313 $ (2,145 ) $ (7,772 ) $ (3,600 ) Depreciation of property, equipment and software 1,762 162 279 — 2,203 Amortization of intangible assets 438 37 387 — 862 EBITDA $ 8,204 $ 512 $ (1,479 ) $ (7,772 ) $ (535 ) Other loss (income) — 9 — (28 ) (19 ) Foreign currency transaction (gains) losses on short-term intercompany balances (73 ) 399 (6 ) (114 ) 206 Transformation, severance, and other expenses 128 123 18 428 697 Stock-based compensation — — — 1,384 1,384 Adjusted EBITDA from continuing operations $ 8,259 $ 1,043 $ (1,467 ) $ (6,102 ) $ 1,733

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	Debt On March 14, 2019, the Company, as co-borrower with PRGX USA, Inc. (“PRGX-USA” and, collectively with the Company, the "Borrowers"), a wholly-owned subsidiary that is the Company’s principal domestic operating subsidiary, entered into a five -year Credit Agreement (the “BOA Credit Facility”) with Bank of America, N.A. (“BOA”) and Synovus Bank as the initial lenders thereunder, and with BOA as the letter-of-credit issuer thereunder, as the swingline lender thereunder, and as the administrative agent (the “Administrative Agent”) for the lenders from time to time party thereto. The BOA Credit Facility consists of a $60.0 million senior revolving credit facility (the “Revolver”), with a $5.0 million subfacility for the issuance of letters of credit, and a $5.0 million swingline loan subfacility (the “Swingline Loan”). The BOA Credit Facility is guaranteed by each of PRGX’s direct and indirect domestic wholly-owned subsidiaries (other than PRGX-USA), except for certain immaterial domestic subsidiaries. None of PRGX’s direct or indirect foreign subsidiaries have guaranteed the BOA Credit Facility. The BOA Credit Facility is secured by substantially all of the assets of PRGX, PRGX-USA and each guarantor (including the equity interests in substantially all of the Company’s domestic subsidiaries and up to sixty-five percent ( 65% ) of the equity interests of certain of the Company’s first-tier material foreign subsidiaries). In connection with the closing of the BOA Credit Facility, PRGX borrowed $30.0 million under the Revolver, substantially all of which was used to prepay in full the approximately $29.0 million in outstanding indebtedness owed to the lenders under PRGX’s pre-existing Amended & Restated Revolving Credit Agreement, dated December 23, 2014, as amended from time to time, by and among PRGX, PRGX-USA, the several banks and other financial institutions and lenders from time to time party thereto and SunTrust Bank, in its capacity as administrative agent for the lenders (the "SunTrust Credit Facility"), and to terminate that prior credit facility in its entirety. There were no early termination penalties associated with the termination of the SunTrust Credit Facility. The BOA Credit Facility will mature on March 14, 2024. Interest is payable quarterly in arrears. There are no prepayment penalties in the event the Company elects to prepay and terminate the BOA Credit Facility prior to its scheduled maturity date, subject to breakage and redeployment costs in certain limited circumstances. The Revolver bears interest at a rate per annum comprised of a specified index rate based on LIBOR plus an applicable interest rate margin determined under the BOA Credit Facility. For U.S. Dollar-denominated loans under the Revolver, at the option of the Borrowers, such loans shall bear interest at a rate per annum equal to (x) the LIBOR daily floating rate plus an applicable interest rate margin determined under the BOA Credit Facility or (y) the base rate plus the applicable interest rate margin, each as determined under the BOA Credit Facility. Although the Company does not anticipate the need for Swingline Loans, were any Swingline Loans to be made they would bear interest at the base rate plus the applicable interest rate margin for base rate loans, each as determined under the BOA Credit Facility. The applicable interest rate margin varies from 1.50% per annum to 2.25% per annum, for LIBOR daily floating rate loans, and from 0.50% per annum to 1.25% per annum, for loans based on the base rate, and in either case depending on the Company’s consolidated leverage ratio, and is determined in accordance with a pricing grid under the BOA Credit Facility. The BOA Credit Facility includes customary affirmative, negative, and financial covenants binding on the Company, including delivery of financial statements and other reports and maintenance of existence. The negative covenants limit the ability of the Company, among other things, to incur debt, incur liens, make investments and sell assets, but does provide for certain permitted repurchases of shares of its capital stock and the declaration and payment of certain dividends on its capital stock. The financial covenants included in the BOA Credit Facility set forth a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio for the Company, each which will be tested on a quarterly basis; and with the Company having the ability to increase the maximum leverage ratio for a limited time when needed in connection with permitted acquisitions. In addition, the BOA Credit Facility includes customary events of default. As of March 31, 2020, there was $45.0 million in debt outstanding under the BOA Credit Facility that will be due March 14, 2024. The amount available for additional borrowing under the BOA Credit Facility was $15.0 million as of March 31, 2020. Based on the terms of the BOA Credit Facility, on March 31, 2020 the applicable interest rate (inclusive of the applicable interest rate margin) for LIBOR daily floating rate loans (the only type outstanding on March 31, 2020) was approximately 2.74% . As of March 31, 2020, the Company was required to pay a commitment fee of 0.25% per annum, payable quarterly, on the unused portion of the BOA Credit Facility. As of March 31, 2020 As of December 31, 2019 Credit facility (1) $ 45,000 $ 37,000 DFC (2) (373 ) (397 ) Net credit facility 44,627 36,603 Finance lease obligations (1) 4 17 Total debt 44,631 36,620 Less: Current portion of long-term debt 4 17 Long-term debt, excluding current portion $ 44,627 $ 36,603 (1) Principal portion of long-term debt. Refer to Future Commitments table below for principal payments to be made on long-term debt. (2) DFC refers to deferred financing costs related to the Company's long-term debt. Future Commitments The following is a summary of the combined principal maturities of all long-term debt and principal payments to be made under the Company’s finance lease agreements for each of the fiscal years presented in the table below (in thousands): Year Ending December 31, 2020 $ 4 2021 — 2022 — 2023 — 2024 45,000 Total $ 45,004

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company records cash equivalents at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled receivables, accounts payable, deferred revenue and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short-term maturity of these items. The Company records bank debt, if any, as of the period end date based on the effective borrowing rate and repayment terms when originated. The Company had $45.0 million in bank debt outstanding as of March 31, 2020 and $37.0 million in bank debt outstanding as of December 31, 2019 . The Company believes the carrying value of the bank debt approximates its fair value. The Company considers the factors used in determining the fair value of this debt to be Level 3 inputs (significant unobservable inputs). The Company states certain assets at fair value on a nonrecurring basis as required by GAAP. Generally, these assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings The Company is party to a variety of legal proceedings arising in the normal course of business. While the results of these proceedings cannot be predicted with certainty, management believes that the final outcome of these proceedings will not have a material adverse effect on the Company's financial position, results of operations or cash flows.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Reported income tax expense in each period primarily results from taxes on the income of foreign subsidiaries. The effective tax rates generally differ from the expected tax rate due primarily to the Company’s deferred tax asset valuation allowance on the domestic earnings and taxes on income of foreign subsidiaries. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. In addition, the Company is subject to the continuous examination of its income tax returns by the Internal Revenue Service in the U.S. and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. The Company applies a “more-likely-than-not” recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. PRGX refers to GAAP for guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. In accordance with FASB ASC 740, the Company's policy for recording interest and penalties associated with tax positions is to record such items as a component of income before income taxes. A number of years may elapse before a tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments also varies by tax jurisdiction.

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	Leases The Company primarily leases office space and certain office equipment using noncancelable operating leases. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the implicit rate is not readily determinable in most of the Company's lease agreements, the Company uses its estimated secured incremental borrowing rate, which takes into consideration the relevant term of the underlying lease, in determining the present value of lease payments. Lease expense is recognized on a straight-line basis over the lease terms. Certain of our lease agreements include variable lease payments, primarily related to common area maintenance, insurance and taxes. The variable portion of payments is not included in the initial measurement of the right-of-use asset or lease liability due to the uncertainty of the payment amount and are recorded as lease expense in the period incurred. The Company's leases have original lease periods expiring between 2020 and 2027, which may include the option to extend the lease when it is reasonably certain the Company will exercise that option. The Company does not have lease agreements with residual value guarantees, sale leaseback terms or material restrictive covenants. The components of lease expense, lease term and discount rate are as follows (in thousands): Three Months Ended March 31, 2020 Three Months Ended March 31, 2019 Operating lease cost $ 1,101 $ 1,266 Short-term lease cost 17 21 Variable lease cost 194 43 Sublease income (18 ) (17 ) Total lease cost $ 1,294 $ 1,313 As of March 31, 2020, the weighted average remaining lease term and weighted average discount rate for the Company's operating leases were as follows: Operating Leases Weighted Average Remaining Lease Term 3.3 years Weighted Average Discount Rate 3.8 % The following is a schedule, by years, of maturities of lease liabilities as of March 31, 2020 (in thousands): Operating Leases The remainder of 2020 $ 3,998 2021 3,342 2022 1,549 2023 1,065 2024 509 Thereafter 282 Total undiscounted cash flows 10,745 Less imputed interest (602 ) Present value of lease liabilities $ 10,143 Supplemental cash flow information related to the Company's operating leases are as follows (in thousands): Three Months Ended March 31, 2020 Non-cash activity: Right-of-use assets obtained in exchange for operating lease obligations $ — Operating cash flows: Cash paid for amounts included in the measurement of lease liabilities $ 1,070

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Impact of Recently Issued Accounting Standards	Impact of Recently Issued Accounting Standards A summary of the new accounting standards issued by the FASB and included in the Accounting Standards Codification ("ASC") that apply to PRGX is included below: Adopted by the Company in Fiscal Year 2020 FASB ASU 2018-13 - In August 2018, the FASB issued Accounting Standards Update ("ASU") 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement , which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public companies are required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. Certain provisions of the ASU must be applied retrospectively, while others must be applied prospectively. The Company adopted this ASU on January 1, 2020. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements. FASB ASU 2018-15 - In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract , which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The Company adopted this ASU prospectively on January 1, 2020. The adoption of this ASU did not have a material impact on the Company's condensed consolidated financial statements. Accounting Standards Not Yet Adopted FASB ASU 2016-13 - In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which requires entities to record expected credit losses for certain financial instruments, including trade receivables, as an allowance that reflects the entity's current estimate of credit losses expected to be incurred. ASU 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods, and early adoption is permitted. The Company is currently evaluating the effect that the adoption of this standard will have on the Company's condensed consolidated financial statements. FASB ASU 2019-12 - In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which simplifies accounting for income taxes, changes the accounting for certain income tax transactions and makes certain improvements to the codification. These amendments will be effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the new standard to determine the impact it will have on the Company’s condensed consolidated financial statements. FASB ASU 2020-04 - In March 2020, the FASB issued ASU No. 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (LIBOR) and other interbank offered rates. Companies may adopt this guidance at any time but no later than December 31, 2022. The Company is currently evaluating the new standard to determine the impact it will have on the Company’s condensed consolidated financial statements.
Fair value of financial instruments	Fair Value of Financial Instruments The Company records cash equivalents at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled receivables, accounts payable, deferred revenue and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short-term maturity of these items. The Company records bank debt, if any, as of the period end date based on the effective borrowing rate and repayment terms when originated. The Company had $45.0 million in bank debt outstanding as of March 31, 2020 and $37.0 million in bank debt outstanding as of December 31, 2019 . The Company believes the carrying value of the bank debt approximates its fair value. The Company considers the factors used in determining the fair value of this debt to be Level 3 inputs (significant unobservable inputs). The Company states certain assets at fair value on a nonrecurring basis as required by GAAP. Generally, these assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.
Income Taxes	Income Taxes Reported income tax expense in each period primarily results from taxes on the income of foreign subsidiaries. The effective tax rates generally differ from the expected tax rate due primarily to the Company’s deferred tax asset valuation allowance on the domestic earnings and taxes on income of foreign subsidiaries. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. In addition, the Company is subject to the continuous examination of its income tax returns by the Internal Revenue Service in the U.S. and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. The Company applies a “more-likely-than-not” recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. PRGX refers to GAAP for guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. In accordance with FASB ASC 740, the Company's policy for recording interest and penalties associated with tax positions is to record such items as a component of income before income taxes. A number of years may elapse before a tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments also varies by tax jurisdiction.

Net Loss Per Common Share (Tabl

Net Loss Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Computations of basic and diluted earnings (loss) per common share	The following table sets forth the computations of basic and diluted net loss per common share for the three months ended March 31, 2020 and 2019 (in thousands, except per share data): Three Months 2020 2019 Numerator: Net loss from continuing operations $ (3,883 ) $ (4,241 ) Net loss from discontinued operations $ — $ (155 ) Denominator: Weighted-average common shares outstanding 22,488 22,610 Basic net loss per common share from continuing operations $ (0.17 ) $ (0.19 ) Basic net loss per common share from discontinued operations — (0.01 ) Total basic net loss per common share $ (0.17 ) $ (0.20 ) Diluted loss per common share from continuing operations $ (0.17 ) $ (0.19 ) Diluted loss per common share from discontinued operations — (0.01 ) Total diluted loss per common share $ (0.17 ) $ (0.20 ) Anti-dilutive securities excluded from diluted net loss per share calculation 5,263 4,139

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Share-based Compensation, Activity	The following is a summary of grant activity for the three months ended March 31, 2020 (in thousands, except number of awards): Three Months Ended March 31, 2020 # of Awards Granted Grant Date Fair Value Restricted stock 398,500 $ 1,710 Restricted stock units 19,000 82 PBUs 659,301 2,828 1,076,801 $ 4,620

Operating Segments and Relate_2

Operating Segments and Related Information (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of discontinued operations information	The following table presents the discontinued operations of the Healthcare Claims Recovery Audit ("HCRA") services business in the Consolidated Statement of Operations, for the three months ended March 31, 2019 (in thousands): Three Months Ended March 31, 2019 Revenue, net $ — Cost of sales 149 Selling, general and administrative expense 6 Depreciation and amortization — Loss from discontinued operations before income taxes $ (155 ) Income tax expense — Loss from discontinued operations $ (155 ) The following table presents the discontinued operations of the HCRA services business in the Consolidated Statements of Cash Flows, for the three months ended March 31, 2019 (in thousands): Three Months Ended March 31, 2019 Net cash used in operating activities $ (155 ) Net cash (used in) provided by investing activities — Net cash (used in) provided by financing activities — Decrease in cash and cash equivalents $ (155 )
Segment information	Segment information for the three months ended March 31, 2020 and 2019 (in thousands) is as follows: Recovery Audit Services – Americas Recovery Audit Services – Europe/Asia- Pacific Adjacent Services Corporate Support Total Three Months Ended March 31, 2020 Revenue, net $ 26,223 $ 9,785 $ 831 $ — $ 36,839 Net loss from continuing operations (3,883 ) Income tax benefit (44 ) Interest expense, net 342 EBIT $ 4,478 $ 1,439 $ 138 $ (9,640 ) $ (3,585 ) Depreciation of property, equipment and software 1,938 169 34 — 2,141 Amortization of intangible assets 408 42 379 — 829 EBITDA $ 6,824 $ 1,650 $ 551 $ (9,640 ) $ (615 ) Foreign currency transaction losses (gains) on short-term intercompany balances 896 874 4 (318 ) 1,456 Transformation, severance, and other expenses 688 208 80 331 1,307 Stock-based compensation — — — 1,320 1,320 Adjusted EBITDA from continuing operations $ 8,408 $ 2,732 $ 635 $ (8,307 ) $ 3,468 Recovery Audit Services – Americas Recovery Audit Services – Europe/Asia- Pacific Adjacent Services Corporate Support Total Three Months Ended March 31, 2019 Revenue, net $ 27,373 $ 9,759 $ 1,672 $ — $ 38,804 Net loss from continuing operations (4,241 ) Income tax expense 168 Interest expense, net 473 EBIT $ 6,004 $ 313 $ (2,145 ) $ (7,772 ) $ (3,600 ) Depreciation of property, equipment and software 1,762 162 279 — 2,203 Amortization of intangible assets 438 37 387 — 862 EBITDA $ 8,204 $ 512 $ (1,479 ) $ (7,772 ) $ (535 ) Other loss (income) — 9 — (28 ) (19 ) Foreign currency transaction (gains) losses on short-term intercompany balances (73 ) 399 (6 ) (114 ) 206 Transformation, severance, and other expenses 128 123 18 428 697 Stock-based compensation — — — 1,384 1,384 Adjusted EBITDA from continuing operations $ 8,259 $ 1,043 $ (1,467 ) $ (6,102 ) $ 1,733

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	As of March 31, 2020 As of December 31, 2019 Credit facility (1) $ 45,000 $ 37,000 DFC (2) (373 ) (397 ) Net credit facility 44,627 36,603 Finance lease obligations (1) 4 17 Total debt 44,631 36,620 Less: Current portion of long-term debt 4 17 Long-term debt, excluding current portion $ 44,627 $ 36,603 (1) Principal portion of long-term debt. Refer to Future Commitments table below for principal payments to be made on long-term debt. (2) DFC refers to deferred financing costs related to the Company's long-term debt.
Schedule of Maturities of Long-term Debt	The following is a summary of the combined principal maturities of all long-term debt and principal payments to be made under the Company’s finance lease agreements for each of the fiscal years presented in the table below (in thousands): Year Ending December 31, 2020 $ 4 2021 — 2022 — 2023 — 2024 45,000 Total $ 45,004

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Components of Lease Expense, Lease Term and Discount Rate	The components of lease expense, lease term and discount rate are as follows (in thousands): Three Months Ended March 31, 2020 Three Months Ended March 31, 2019 Operating lease cost $ 1,101 $ 1,266 Short-term lease cost 17 21 Variable lease cost 194 43 Sublease income (18 ) (17 ) Total lease cost $ 1,294 $ 1,313
Weighted Average Remaining Lease Term and Weighted Average Discount Rate	As of March 31, 2020, the weighted average remaining lease term and weighted average discount rate for the Company's operating leases were as follows: Operating Leases Weighted Average Remaining Lease Term 3.3 years Weighted Average Discount Rate 3.8 %
Maturity of Lease Liabilities	The following is a schedule, by years, of maturities of lease liabilities as of March 31, 2020 (in thousands): Operating Leases The remainder of 2020 $ 3,998 2021 3,342 2022 1,549 2023 1,065 2024 509 Thereafter 282 Total undiscounted cash flows 10,745 Less imputed interest (602 ) Present value of lease liabilities $ 10,143
Supplemental Cash Flow Information	Supplemental cash flow information related to the Company's operating leases are as follows (in thousands): Three Months Ended March 31, 2020 Non-cash activity: Right-of-use assets obtained in exchange for operating lease obligations $ — Operating cash flows: Cash paid for amounts included in the measurement of lease liabilities $ 1,070

Basis of Presentation Basis of

Basis of Presentation Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2020USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Goodwill and intangible asset impairment	$ 0

Net Loss Per Common Share (Deta

Net Loss Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Numerator:
Net loss from continuing operations	$ (3,883)	$ (4,241)
Net loss from discontinued operations	$ 0	$ (155)
Denominator:
Weighted-average common shares outstanding	22,488	22,610
Basic net (loss) income per common share from continuing operations (in usd per share)	$ (0.17)	$ (0.19)
Basic net income (loss) per common share from discontinued operations (in usd per share)	0	(0.01)
Total basic net loss per common share	(0.17)	(0.20)
Diluted (loss) income per common share from continuing operations (in usd per share)	(0.17)	(0.19)
Diluted income (loss) per common share from discontinued operations (in usd per share)	0	(0.01)
Total diluted (loss) income per common share (in usd per share)	$ (0.17)	$ (0.20)
Anti-dilutive securities excluded from diluted net loss per share calculation (in shares)	5,263	4,139

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)compensation_planshares	Mar. 31, 2019USD ($)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Number of stock-based compensation plans | compensation_plan	2
Compensation expense | $	$ 1.3	$ 1.4
Shares available for grant (in shares)	900,000
Nonvested awards compensation costs not yet recognized | $	$ 9
Nonvested awards, compensation costs not yet recognized, period for recognition	2 years 12 days
Restricted Stock [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Grants other than options (in shares)	398,500
Restricted Stock Units (RSUs) [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Grants other than options (in shares)	19,000
Performance-Based Restricted Stock Units [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Performance period	2 years
Grants other than options (in shares)	659,301
Target percent for PBU's used to calculate stock compensation expense (percent)		100.00%
Awards Vesting over 3 Years, Grant 1 [Member] | Restricted Stock [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Performance period	3 years

Stock-Based Compensation Stock-

Stock-Based Compensation Stock-Based Compensation Grant Date Fair Value (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity grants in period (in shares) | shares	1,076,801
Equity grants in period, grant date fair value | $	$ 4,620
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants other than options (in shares) | shares	398,500
Grants other than options, grant date fair value | $	$ 1,710
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants other than options (in shares) | shares	19,000
Grants other than options, grant date fair value | $	$ 82
Performance-Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants other than options (in shares) | shares	659,301
Grants other than options, grant date fair value | $	$ 2,828

Operating Segments and Relate_3

Operating Segments and Related Information - Narrative (Details)	3 Months Ended
	Mar. 31, 2020segment
Segment Reporting [Abstract]
Number of reportable segments	3

Operating Segments and Relate_4

Operating Segments and Related Information - Results of Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting [Abstract]
Revenue, net		$ 0
Cost of sales		149
Selling, general and administrative expense		6
Depreciation and amortization		0
Loss from discontinued operations before income taxes	$ 0	(155)
Income tax expense		0
Loss from discontinued operations		$ (155)

Operating Segments and Relate_5

Operating Segments and Related Information Operating Segments and Related Information - Discontinued Statement of Cash Flows (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019USD ($)
Segment Reporting [Abstract]
Net cash used in operating activities	$ (155)
Net cash (used in) provided by investing activities	0
Net cash (used in) provided by financing activities	0
Decrease in cash and cash equivalents	$ (155)

Operating Segments and Relate_6

Operating Segments and Related Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment information
Revenue, net	$ 36,839	$ 38,804
Net loss from continuing operations	(3,883)	(4,241)
Income tax expense	(44)	168
Interest expense, net	342	473
EBIT	(3,585)	(3,600)
Depreciation of property, equipment and software	2,141	2,203
Amortization of intangible assets	829	862
EBITDA	(615)	(535)
Other loss (income)	0	(19)
Foreign currency transaction losses (gains) on short-term intercompany balances	1,456	206
Transformation, severance, and other expenses	1,307	697
Stock-based compensation	1,320	1,384
Adjusted EBITDA from continuing operations	3,468	1,733
Recovery Audit Services - Americas [Member]
Segment information
Revenue, net	26,223	27,373
EBIT	4,478	6,004
Depreciation of property, equipment and software	1,938	1,762
Amortization of intangible assets	408	438
EBITDA	6,824	8,204
Other loss (income)		0
Foreign currency transaction losses (gains) on short-term intercompany balances	896	(73)
Transformation, severance, and other expenses	688	128
Stock-based compensation	0	0
Adjusted EBITDA from continuing operations	8,408	8,259
Recovery Audit Services - Europe/Asia-Pacific [Member]
Segment information
Revenue, net	9,785	9,759
EBIT	1,439	313
Depreciation of property, equipment and software	169	162
Amortization of intangible assets	42	37
EBITDA	1,650	512
Other loss (income)		9
Foreign currency transaction losses (gains) on short-term intercompany balances	874	399
Transformation, severance, and other expenses	208	123
Stock-based compensation	0	0
Adjusted EBITDA from continuing operations	2,732	1,043
Adjacent Services [Member]
Segment information
Revenue, net	831	1,672
EBIT	138	(2,145)
Depreciation of property, equipment and software	34	279
Amortization of intangible assets	379	387
EBITDA	551	(1,479)
Other loss (income)		0
Foreign currency transaction losses (gains) on short-term intercompany balances	4	(6)
Transformation, severance, and other expenses	80	18
Stock-based compensation	0	0
Adjusted EBITDA from continuing operations	635	(1,467)
Corporate Support [Member]
Segment information
Revenue, net	0	0
EBIT	(9,640)	(7,772)
Depreciation of property, equipment and software	0	0
Amortization of intangible assets	0	0
EBITDA	(9,640)	(7,772)
Other loss (income)		(28)
Foreign currency transaction losses (gains) on short-term intercompany balances	(318)	(114)
Transformation, severance, and other expenses	331	428
Stock-based compensation	1,320	1,384
Adjusted EBITDA from continuing operations	$ (8,307)	$ (6,102)

Debt (Narrative) (Details)

Debt (Narrative) (Details) - USD ($)	Mar. 14, 2019	Mar. 31, 2020	Dec. 31, 2019
Line of Credit Facility [Line Items]
Amount of line of credit outstanding		$ 44,627,000	$ 36,603,000
Revolving Credit Facility [Member] | Line of Credit [Member] | Bank Of America [Member]
Line of Credit Facility [Line Items]
Credit facility, term	5 years
Line of credit facility, increase, net	$ 60,000,000
Maximum borrowing capacity of credit facility	5,000,000
Amount of line of credit outstanding	30,000,000	$ 45,000,000
debt outstanding, prepayment	29,000,000
Stated interest rate		2.74%
Remaining borrowing capacity		$ 15,000,000
Commitment fee		0.25%
Bridge Loan [Member] | Line of Credit [Member] | Bank Of America [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity of credit facility	$ 5,000,000
Debt instrument secured, equity interest, percentage	65.00%
Minimum [Member] | Senior Notes [Member]
Line of Credit Facility [Line Items]
Stated interest rate	1.50%
Minimum [Member] | Base Rate [Member] | Senior Notes [Member]
Line of Credit Facility [Line Items]
Stated interest rate	0.50%
Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member] | Senior Notes [Member]
Line of Credit Facility [Line Items]
Stated interest rate	2.25%
Maximum [Member] | Base Rate [Member] | Senior Notes [Member]
Line of Credit Facility [Line Items]
Stated interest rate	1.25%

Debt (Schedule of Debt) (Detail

Debt (Schedule of Debt) (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Total	$ 45,004
Net credit facility	44,631	$ 36,620
Current portion of debt	4	17
Long-term debt, excluding current portion	44,627	36,603
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Total	45,000	37,000
DFC	(373)	(397)
Net credit facility	44,627	36,603
Finance Lease Obligations [Member]
Debt Instrument [Line Items]
Net credit facility	$ 4	$ 17

Debt (Future Minimum Liabilitie

Debt (Future Minimum Liabilities) (Details) $ in Thousands	Mar. 31, 2020USD ($)
Debt Disclosure [Abstract]
2020	$ 4
2021	0
2022	0
2023	0
2024	45,000
Total	$ 45,004

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Bank Loan Obligations [Member]
Fair Value of Financial Instruments (Textual) [Abstract]
Fair value of long term debt	$ 45	$ 37

Leases - Components of Lease Ex

Leases - Components of Lease Expense, Lease Term and Discount Rate (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease cost	$ 1,101	$ 1,266
Short-term lease cost	17	21
Variable lease cost	194	43
Sublease income	(18)	(17)
Total lease cost	$ 1,294	$ 1,313
Weighted Average Remaining Lease Term	3 years 3 months 18 days
Weighted Average Discount Rate	3.80%

Leases - Operating Lease, Matur

Leases - Operating Lease, Maturity of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Jan. 01, 2019
Leases [Abstract]
The remainder of 2020	$ 3,998
2021	3,342
2022	1,549
2023	1,065
2024	509
Thereafter	282
Total undiscounted cash flows	10,745
Less imputed interest	(602)
Present value of lease liabilities	$ 10,143	$ 14,400

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Non-cash activity:
Right-of-use assets obtained in exchange for operating lease obligations	$ 0
Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities	$ 1,070